| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |